Straumann Holding AGXSWX:STMN +1.65%100 Graham Number is CHF23.27 as of Dec. 2025, which is 100% below its 10-year median of 5.85. GuruFocus rates XSWX:STMN with a GF Score™ of 100/100 and a GF Value™ of CHF137.24 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 398 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 86.68% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-07-04), the stock price of Straumann Holding AG is CHF107.65. Straumann Holding AG's graham number for the quarter that ended in Dec. 2025 was CHF23.27. Therefore, Straumann Holding AG's Price to Graham Number ratio for today is 4.63.
The historical rank and industry rank for Straumann Holding AG's Graham Number or its related term are showing as below:
XSWX:STMN'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 4.02 Med: 5.85 Max: 10.45
Current: 4.63
During the past 13 years, the highest Price to Graham Number ratio of Straumann Holding AG was 10.45. The lowest was 4.02. And the median was 5.85.
XSWX:STMN's Price-to-Graham-Number is ranked worse than 86.68% of 398
companies
in the Medical Devices & Instruments industry
Industry Median: 1.83
vs XSWX:STMN: 4.63
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Straumann Holding AG (XSWX:STMN) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Straumann Holding AG's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Dec. 2025 )
=
107.65
/
23.27
=
4.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Straumann Holding AG Graham Number Related Terms
Straumann Holding AG Graham Number Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Graham Number Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Price-to-Graham-Number vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Graham Number of CHF23.27 as of Dec. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Straumann Holding AG and its competitors. This is 298% above median its historical median of 5.85. Over the past decade, Straumann Holding AG's Graham Number has ranged from 4.02 to 10.45. According to the industry distribution chart, Straumann Holding AG ranks #345 out of 398 companies in the Medical Devices & Instruments industry, placing it in the top 86.7%.
Is Straumann Holding AG's Graham Number too high?
Straumann Holding AG's current Graham Number of CHF23.27 is 298% above median its 10-year median of 5.85. Over the past 10 years, this metric has ranged from a low of 4.02 to a high of 10.45. Based on the distribution chart, Straumann Holding AG ranks #345 out of 398 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Straumann Holding AG has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Graham Number compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #345 out of 398 companies for Graham Number. This places Straumann Holding AG in the lower half of its industry. The industry median Graham Number is 1.83. Historically, Straumann Holding AG's own Graham Number has ranged from 4.02 to 10.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Medical Devices & Instruments company?
The median Graham Number among Medical Devices & Instruments companies is 1.83, based on 398 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Graham Number is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Graham Number is CHF23.27, which is 298% above median its own 10-year median of 5.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.24, compared to a current price of CHF107.65 — trading 21.6% below its estimated fair value. The current Graham Number is CHF23.27, which is 298% above median its 10-year median of 5.85. Straumann Holding AG's overall GF Score™ is 100/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Graham Number is CHF23.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF107.65 is trading 21.6% below its estimated GF Value™ of CHF137.24.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Graham Number: CHF23.27 (298% above median its 10-year median of 5.85)
GF Value™: CHF137.24 vs. price of CHF107.65 (21.6% below fair value)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
100GF Score
Get the complete analysis for XSWX:STMN
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
